Subnormal serum vitamin B12 and behavioural and psychological symptoms in Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 15, Issue 5, 2000, Pages 415-418

  Meins, Wolfgang ^a,b   Müller Thomsen, Tomas ^c   Meier Baumgartner, Hans Peter ^a  

^a ALBERTINEN KRANKENHAUS   (Germany)

^b Albertinen Haus   (Germany)

^c NONE

Author keywords

Alzheimer's disease; Behaviour disturbances; Behavioural and psychological symptoms of dementia; Cobalamin; Irritability

Indexed keywords

CYANOCOBALAMIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAMIN B 12 DEFICIENCY;

EID: 0342657219     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(200005)15:5<415::AID-GPS123>3.0.CO;2-E     Document Type: Article

References (26)

1. Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1988) Cornell Scale for Depression in dementia. Biol. Psychiat. 23, 271-284.
2. Allen, N. H. P. and Burns, A. (1995) The noncognitive features of dementia. Rev. Clin. Gerontol. 5, 57-75.
3. Basun, H., Fratiglioni, L. and Winblad, B. (1994) Cobalamin levels are not reduced in Alzheimer's disease: results from a population based study. J. Am. Geriatr. Soc. 42, 132-136.
4. Beal, M. F., Swartz, K. J., Finn, S. F., Mazurek, M. F. and Kowall, N. W. (1991) Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J. Neurosci. 11, 147-158.
5. Boushey, C. J., Beresford, S. A., Omenn, G. S. and Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
6. 12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch. Neurol. 55, 1449-1455.
7. 12 in Alzheimer-type dementia. Age Ageing 13, 101-105.
8. 12 deficiency and dementia. Int. Psychogeriat. 7, 85-88.
9. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975) Mini-Mental State: a practical method for grading the mental state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
10. Green, R. and Kinsella, L. J. (1995) Current concepts in the diagnosis of cobalamin deficiency. Neurology 45, 1435-1440.
11. Hope, T., Keene, J., Fairburn, C. G., Jacoby, R. and McShane, R. (1999) Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. Br. J. Psychiat. 174, 39-44.
12. 12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J. Gerontol. A. Biol. Sci. Med. Sci. 52, M76-79.
13. Karnaze, D. S. and Carmel, R. (1987) Low serum cobalamin levels in primary degenerative dementia. Arch. Intern. Med. 147, 429-431.
14. Kristensen, M. Ø., Gulmann, N. C., Christensen, J. E., Østergaard, K. and Rasmussen, K. (1993) Serum cobalamin and methylmalonic acid in Alzheimer's dementia. Acta Neurol. Scand. 87, 475-481.
15. 12 and cognitive impairment in patients with Alzheimer's disease. Acta. Psychiatr. Scand. 86, 301-305.
16. Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'Emilia, D. M., Rayudu, P. V., Arnelle, D. R. and Stamler, J. S. (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA 94, 5923-5928.
17. Martin, D. C., Francis, J., Protetch, J. and Huff, F. J. (1992) Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J. Am. Geriatr. Soc. 40, 168-172.
18. McCaddon, A., Davies, G., Hudson, P., Tandy, S. and Cattell, H. (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriat. Psychiat. 13, 235-239.
19. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
20. 6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346, 85-89.
21. 12 levels related to high activity of platelet MAO in patients with dementia disorders. Acta Psychiatr. Scand. 78, 451-457.
22. Renvall, M. J., Spindler, A. A., Ramsdell, J. W. and Paskvan, M. (1989) Nutritional status of free-living Alzheimer's patients. Am. J. Med. Sci. 298, 20-27.
23. Spiegel, R., Brunner, C., Ermini-Fünfschilling, D., Monsch, A., Notter, M., Puxty, J. and Tremmel, L. (1991) A new behavioral assessment scale for geriatric out- and inpatients: the NOSGER. J. Am. Geriatr. Soc. 39, 339-347.
24. Stabler, S. P., Allen, R. H., Savage, D. G. and Lindenbaum, J. (1990) Clinical spectrum and diagnosis of cobalamin deficiency. Blood 76, 871-881.
25. 12: effects of replacement therapy on dementia. J. Neurol. 243, 522-529.
26. World Health Organization (1994) Tenth Revision of the International Classification of Diseases, Chapter V (F). Diagnostic criteria for research. Huber, Bern.